Beta-blocking agents and human fat cell adenylate cyclase

Kather, H.; Simon, B.

Research Communications in Chemical Pathology and Pharmacology 18(1): 11-22

1977


ISSN/ISBN: 0034-5164
PMID: 20652
Document Number: 120640
The effects of various beta-blocking agents upon the catecholamine-activated adenylate cyclase of human fat cell ghosts were studied. Both non-selective and cardio-selective beta-blocking drugs are capable in inhibiting the human enzyme system. The concentrations of the non-selective beta-blockers (bupranolol, alprenolol, propranolol, 4-hydroxypropranolol, prindolol and oxyprenolol) required to produce half maximal inhibition of isoproterenol-stimulated rates of cAMP-formation were found to be in a narrow range (5X10(-7) M-3X10(-6) M).The cardioselective beta-blocking agents, however, were only 1/100 (methypranol) to 1/1000 (atenolol, practolol) as potent as the non-selective drugs.

Document emailed within 1 workday
Secure & encrypted payments